Pacira Corp (PCRX) Amount of Cash per Share

Corporate emblem and logo of Pacira Corp (PCRX)

Pacira BioSciences relies on the steady production of long-acting analgesics amid high capacity utilization. Cash distribution per share demonstrates financial stability, where the current parameter equals 7.36. Growth potential is driven by unique non-opioid drug delivery methods and strict patent control over Exparel, which creates insurmountable barriers for competitors in the medical field.

Pacira Pharmaceuticals (PCRX): Cash per Single Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for Pacira Pharmaceuticals (PCRX)

- market value and analyst target forecast:
- cash position and cash flow details:
Comprehensive company analysis:PCRX (Pacira Corp)
Brand item of Pacira BioSciences, Inc.

To objectively assess the operational efficiency of Pacira BioSciences (PCRX), it is essential for investors to understand how successfully the company converts profit into liquid reserves. By analyzing the cash position on a per-share basis, one can determine the volume of free funds per security, which is critical for maintaining patent protection and funding the costly training of physicians to integrate long-acting analgesics into hospital protocols.

Analysis of competing companies

Cash on Hand per Share Haleon Corp HLN|Cash per Single Share KVUE (Kenvue Health)|Verona Pharma plc - Cash Funds per Single Share|Jyong Biotech - Cash per Single Share|LGND: Cash Funds per Single Share|AMRX: Cash per Single Share|Cash on Hand per Share Perrigo Company plc|ALVO: Cash per Share|Liquidia (LQDA) - Cash per Share|Cash Funds per Share Galapagos N.V.|Cash per Single Share ANI Pharmaceuticals, Inc. (ANIP)|Cash per Share MNKD|AMPH (Amphastar Corp) - Amount of Cash per Share|Cash per Share SPRY (ars-pharma.com)|Amount of Cash per Share TBPH|Aquestive Therapeutics, Inc. - Cash per Share|scpharmaceuticals.com - Cash Calculated per Single Share|Tectonic (TECX) - Cash Funds per Share|Cash per Single Share Tonix Pharmaceuticals Inc.|Cash Funds per Share sxtchina.com|Cash per Single Share Eupraxia Pharmaceuticals (EPRX)|Cash per Share BHST|EXOZ - Cash on Hand per Share|Oramed - Cash per Single Share|Entera Bio Ltd. (ENTX) - Cash on Hand per Share|HYFT - Cash Funds per Share|ABVC: Cash Funds per Share|CPIX: Cash per Share|Quantum BioPharma Ltd. - Amount of Cash per Share|FGEN (FibroGen Corp) - Cash per Share|Telomir Pharma (TELO) - Cash Funds Calculated per Share|Cash Funds per Share Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Amount of Cash per Share|Cash Funds per Share Rallybio Corporation RLYB|LEXX: Cash Funds per Single Share|PULM - Cash Funds per Share|Amount of Cash per Share PTHL (Pheton Holdings)|Aptorum (APM) - Cash Funds per Share|LYRA (Lyra Therapeutics) - Cash Funds per Share|Cash Funds per Share Impact BioMedical Inc|TNF Pharmaceuticals - Cash Money per Share|Cash per Share YCBD|Cash per Share PainReform Ltd. (PRFX)|Cash Funds per Share Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Cash Money per Share|OptiNose - Cash per Share|Cash Money per Share PIRS|PROC: Cash per Share|Petros - Amount of Cash per Share|Cash per Single Share QLI|SLRN: Amount of Cash per Share|Cash per Single Share TFFP (TFF Pharmaceuticals, Inc.)